Leap Therapeutics Stock Target Price and Analyst Consensus
| LPTX Stock | USD 2.55 0.03 1.16% |
The current analyst and expert consensus on Leap Therapeutics is Strong Buy, with only one strong buy opinion. The current projected Leap Therapeutics target price consensus is 9.83 with 3 analyst opinions. Check out Macroaxis Advice on Leap Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Leap Stock please use our How to Invest in Leap Therapeutics guide.The most common way Leap Therapeutics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Leap Therapeutics executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Leap Therapeutics. We encourage you to use your own analysis of Leap Therapeutics to validate this buy or sell advice. Leap Therapeutics buy-or-sell recommendation module provides average expert sentiment on the projected Leap Therapeutics target price to derive its highest and lowest estimates based on projected price volatility of 6.0413.
Lowest Forecast 8.95 | Highest Forecast 10.91 | Target Price 9.83 |
Leap |
It's important to approach Leap Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Leap Therapeutics Target Price Consensus
Leap target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Leap Therapeutics' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 3 | Strong Buy |
Most Leap analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Leap stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Leap Therapeutics, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationLeap Therapeutics Target Price Projection
Leap Therapeutics' current and average target prices are 2.55 and 9.83, respectively. The current price of Leap Therapeutics is the price at which Leap Therapeutics is currently trading. On the other hand, Leap Therapeutics' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Leap Therapeutics Market Quote on 18th of January 2025
Target Price
Analyst Consensus On Leap Therapeutics Target Price
Leap Therapeutics Analyst Ratings
Leap Therapeutics' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Leap Therapeutics stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Leap Therapeutics' financials, market performance, and future outlook by experienced professionals. Leap Therapeutics' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Leap Therapeutics price targets
Leap Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Leap Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:- Look at Leap Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Leap Therapeutics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Leap Therapeutics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Leap Therapeutics is a key component of Leap Therapeutics valuation and have some predictive power on the future returns of a Leap Therapeutics.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Leap Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | USD Crypto Fund Invested less than 1 share | |
 | Macroaxis Index Invested over 10K shares | |
 | Chemicals Invested over 40 shares | |
 | Warren Buffett Holdings Invested over 40 shares |
Additional Tools for Leap Stock Analysis
When running Leap Therapeutics' price analysis, check to measure Leap Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Leap Therapeutics is operating at the current time. Most of Leap Therapeutics' value examination focuses on studying past and present price action to predict the probability of Leap Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Leap Therapeutics' price. Additionally, you may evaluate how the addition of Leap Therapeutics to your portfolios can decrease your overall portfolio volatility.